1Ibrahim EH,Ward S,Sherman G,et al.Experience with a clinical guideline for the treatment of ventilator-associated pneumonia.Crit Care Med,2001,29:1109-1115.
2Wang H,Chen M; China Nosocomial Pathogens Resistance Surveillance Study Group.Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China,1996 to 2002.Diagn Microbiol Infect Dis,2005,51:201-208.
3Bechicchio GV,Baquero F,Hsueh PR,et al.In vitro susceptibilities of Escherichia coli isolated from patients with intraabdominal infections worldwide in 2002-2004:results from SMART (Study for Monitoring Antimicrobial Resistance Trends).Surg Infect (Larchmt),2006,7:537-545.
4Tian SF,Chert BY,Chu YZ,et al.Prevalence of rectal carriage of extended-spectrum beta-lactamase-preducing Escherichia coli among elderly people in community settings in China.Can J Microbiol,2008,54:781-785.
5Colodner R,Rock W,Chazan B,et al.Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.Eur J Clin Microbial Infect Dis,2004,23:163-167.
6Paterson DL,Ko WC,Von Gottherg A,et al.International prospective study of Klebsiella pneumoniae bacteremia:implications of extended-spectrum beta-lactamase production in nosocomial Infections.Ann Intern Med,2004,140:26-32.
7Trouillet JL,Chastre J,Vuagnat A,et al.Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.Am J Respir Crit Care Med,1998,157:531-539.
8Shorr AF,Sherner JH,Jackson WL,et al.Invasive approaches to the diagnosis of ventilator-associated pneumonia:a meta-analysis.Crit Care Meal,2005,33:46-53.
5Alvarez-LermaF. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group[J]. Intensive Care Med, 1996, 22(5):387–394.
6LunaCM, VujacichP, NiedermanMS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia[J]. Chest, 1997, 111(3):676–685.
7RelloJ, GallegoM, MariscalD, et al. The value of routine microbial investigation in ventilator-associated pneumonia[J]. Am J Respir Crit Care Med, 1997, 156(1):196–200.
8KollefMH, WardS. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia[J]. Chest, 1998, 113(2):412–420.
9IbrahimEH, ShermanG, WardS, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting[J]. Chest, 2000, 118(1):146–155.
10IreguiM, WardS, ShermanG, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia[J]. Chest, 2002, 122(1):262–268.
